Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found
Articles 1 records found  
1.
7 p, 593.4 KB Asthma control and COPD symptom burden in patients using fixed-dose combination inhalers (SPRINT study) / Roche, Nicolas (Respiratory Medicine, Cochin Hospital, APHP Centre University of Paris, Institut Cochin (UMR1016), Paris, France) ; Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ; Backer, Vibeke (Copenhagen University. Department of Respiratory Medicine) ; van der Palen, Job (Medisch Spectrum Twente. Medical School Twente) ; Cerveri, Isa (Unit of Respiratory Diseases, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy) ; Gonzalez, Chelo (Unit of Statistics and Data Management, Experior SL, 46139 La Pobla de Farnals, Valencia, Spain) ; Safioti, Guilherme (Teva Pharmaceutical Industries Ltd, Amsterdam, The Netherlands) ; Scheepstra, Irma (Teva Pharmaceutical Industries Ltd, Amsterdam, The Netherlands) ; Patino, Oliver (Teva Pharmaceutical Industries Ltd, Amsterdam, The Netherlands) ; Singh, Dave (Centre for Respiratory Medicine and Allergy, University of Manchester, and the Medicines Evaluation Unit, University Hospital of South Manchester NHS Foundation Trust) ; Universitat Autònoma de Barcelona
Previous studies have found suboptimal control of symptom burden to be widespread among patients with asthma and chronic obstructive pulmonary disease (COPD). The Phase IV SPRINT study was conducted in 10 countries in Europe to assess asthma disease control and COPD symptom burden in patients treated with a fixed-dose combination (FDC) of inhaled corticosteroids (ICS) and long-acting beta agonists (LABAs). [...]
2020 - 10.1038/s41533-019-0159-1
NPJ primary care respiratory medicine, Vol. 30 (january 2020)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.